Related Experiment Videos
[Immune responses in broncho-pulmonary cancer]
A-P Meert1, T Berghmans, C Mascaux
1Département de Médecine Interne, HJ Tagnon, Institut Jules Bordet, Bruxelles, Belgique.
Revue Des Maladies Respiratoires
|October 7, 2003
Summary
Enhancing the anti-tumoral immune response is crucial for cancer therapy. Current research focuses on specific active immunotherapies like anti-tumour vaccines and gene therapy for improved effectiveness.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Context:
- The anti-tumoral immune response is primarily cellular.
- Immuno-suppression is observed in advanced cancer, altering cell-mediated immunity.
- Tumor-infiltrating white cells indicate an active host response.
Purpose:
- To explore strategies for augmenting the anti-tumoral immune response therapeutically.
- To investigate the potential of specific active immunotherapies in cancer treatment.
Summary:
- Various immunotherapies, including non-specific and passive approaches, have yielded limited results.
- Specific active immunotherapies, such as anti-tumour vaccines and gene therapy, are the most actively explored avenues.
- Challenges in immunotherapy include patient targeting, agent specificity, gene expression, and clinical trial risks.
Impact:
- Advances in immunotherapy aim to improve treatment effectiveness for cancer patients.
- Focus on specific active immunotherapies like vaccines and gene therapy holds promise for future cancer treatments.